Activated protein C (APC) resistance, both in its congenital form, due to the factor V Leiden mutation, and in its acquired form, are important risk factors for systemic venous thrombosis. In view of the suspected thrombotic aetiology of some cases of recurrent miscarriage, the prevalence of APC resistance was determined among 1111 consecutive Caucasian women with a history of either recurrent early miscarriage (three or more consecutive pregnancy losses at <12 weeks gestation; n ⍧ 904) or a history of at least one late miscarriage (>12 weeks gestation; n ⍧ 207). A control group of 150 parous Caucasian women with no previous history of adverse pregnancy outcome was also studied. Acquired APC resistance was significantly more common among both women with recurrent early miscarriage (8.8%: 80/904; P ⍧ 0.02) and those with late miscarriage (8.7%: 18/207; P ⍧ 0.04) compared with controls (3.3%: 5/150). In contrast, the frequency of the factor V Leiden allele was similar among (i) women with recurrent early miscarriage (3.3%:60/1808; 58 heterozygotes and one homozygote), (ii) those with late miscarriage (3.9%:16/414; 14 heterozygotes and one homozygote) and (iii) the control group (4.0%:12/300; 12 heterozygotes). Acquired but not congenital APC resistance (due to the factor V Leiden mutation) is associated with both early and late miscarriage.
Introduction
V, known as factor V Leiden (Bertina et al., 1994) . Mutated factor V is resistant to inactivation by APC, resulting in Pregnancy is a hypercoaguable state secondary to an increase increased thrombin generation and a hypercoaguable state. in the concentrations of pro-coagulant factors, a reduction in Acquired APC resistance is associated with lupus anticoagulant the concentrations of the naturally occurring anticoagulant and high concentrations of coagulation factor VIII (Laffan and proteins and a decrease in fibrinolysis (Stirling et al., 1984; Manning, 1996) . Both factor V Leiden and acquired APC Clark et al., 1998) . The hypothesis has been developed, resistance are risk factors for systemic venous thrombosis supported by histological data, that recurrent miscarriage and (de Visser et al., 1999) and factor V Leiden has been reported later pregnancy complications are due to an exaggerated in association with placental thrombosis (Rai et al., 1996 ; haemostatic response during pregnancy which results in Dizon et al., 1997) . thrombosis of the uteroplacental vasculature and subsequent
The prevalence of factor V Leiden and acquired APC fetal loss (Rushton, 1988; Preston et al., 1996; Rai et al., resistance among women with recurrent miscarriage has been 1996b; Younis et al., 1997; Kupferminc et al., 1999) . Such an variably reported to be either similar to or increased compared exaggerated response may be due to a maternal thrombophilic to parous controls (Balasch et al., 1997; Brenner et al., 1997 ; defect such as activated protein C (APC) resistance. Grandone et al., 1997; Dizon-Townson et al., 1997 ; Metz A key component in the anticoagulant pathway is protein et al., 1997; Ridker et al., 1998; Kutteh et al., 1998 ; Souza C, which when activated inhibits the actions of coagulation et al., 1999; Tal et al., 1999) . Previous studies have included factors V and VIII. Resistance to the anticoagulant properties only small numbers of women, have been prone to selection of activated protein C-APC resistance-was first reported in bias and some have not divided women into those with recurrent 1993 (Dahlback et al., 1993) . It was later demonstrated first trimester miscarriage and those with later pregnancy loss. that APC resistance may either be congenital or acquired.
The aim of this study was to address the limitations of Congenital APC resistance is almost exclusively due to a existing data by determining the prevalence of both factor V single point mutation (G → A) at nucleotide position 1691 in Leiden and acquired APC resistance among more than 1000 consecutive women with recurrent miscarriage. the factor V gene, which results in a mutated form of factor 
Materials and methods
prepared by double centrifugation of samples at 2700 g at room Subjects temperature for 20 min and stored at -70°C. APC resistance was The study population comprised 1111 consecutive Caucasian women assessed by measuring the anti-coagulant response in plasma on the with a history of either recurrent early miscarriage (three or more addition of APC (Coatest ® ; Chromogenix, Epsom, Surrey, UK). A consecutive miscarriages at Ͻ12 weeks gestation; n ϭ 904) or a ratio of Ͻ2.26 for the clotting time in the presence of APC/clotting history of at least one late miscarriage (Ͼ12 weeks gestation; n ϭ time in the absence of APC was taken to represent APC resistance 207). The demographic details and outcome of previous pregnancies (Rosen et al., 1994) . of these women are shown in Table I .
A control population of 150 unrelated Caucasian women (median Definitions of congenital and acquired activated protein C resistance parity 1; range 1-3) with no previous history of miscarriage or late Congenital APC resistance was defined as an APC ratio in the pregnancy complication was also studied (Table I) . No woman in Coatest ® of Ͻ2.26 in an individual who carried the factor V Leiden this study had a personal or family history of thrombo-embolic mutation and acquired APC resistance as a ratio of Ͻ2.26 in an disease, was taking the combined oral contraceptive pill, had an individual with a normal factor V genotype. abnormal peripheral blood karyotype or a partner with an abnormal karyotype. All women were investigated at least 12 weeks after their Antiphospholipid antibodies last pregnancy.
All women were screened for aPL on at least two occasions more A variety of causes for recurrent miscarriage has been suggested than 6 weeks apart prior to pregnancy. Lupus anticoagulant was over the decades. However, despite intensive investigation, only detected using the dilute Russell's viper venom time (dRVVT) together antiphospholipid antibodies (aPL)-lupus anticoagulant (LA) and with a platelet neutralization procedure. Patient samples with a anticardiolipin antibodies (aCL)-and parental karyotype abnormalidRVVT ratio (test/control) of ജ1.1 were retested with a platelet ties are established causes for recurrent miscarriage (Royal College neutralization procedure. A decrease of 10% or more in the ratio was of Obstetricians and Gynaecologists, 1998). The prevalence of aPL considered to be positive for lupus anticoagulant (Lupus Anticoagulant in the study cohort was 20.7% (230/1111).
Working Party on behalf of the BCSH Haemostasis and Thrombosis Taskforce, 1991). Anticardiolipin antibodies were identified using a Protocol for the investigation of recurrent miscarriage standardized enzyme linked immunosorbent assay (ELISA). An All women attending the Recurrent Miscarriage Clinic are screened immunoglobulin (Ig)G anticardiolipin value ജ5 GPL units and an for the factor V Leiden mutation, APC resistance and for both LA IgM anticardiolipin value ജ3 MPL units was considered to be positive and aCL prior to pregnancy. In addition, peripheral blood karyotyping (Khamashta and Hughes, 1993) . Women with a positive test for LA is carried out on both partners. or a positive aCL titre had a confirmatory test performed on a second sample taken at least 8 weeks after the initial sample. Only women Factor V Leiden with persistently positive tests for either LA or aCL were considered Genomic DNA was extracted from EDTA whole blood using standard to have the antiphospholipid syndrome. techniques. The polymerase chain reaction (PCR) using known primers was used to amplify exon 10 of the factor V gene which Statistical analysis contains the G → A mutation at nucleotide position 1691 (Bertina Discrete variables were analysed using the χ 2 test and continuous et al., 1994) . Following amplification, a 20 µl aliquot of the product variables analysed using the Mann-Whitney U-test. P values of was digested overnight with 5 IU of the enzyme Mnl I (New England Ͻ 0.05 were taken as statistically significant. Biolabs, Hitchin, Herts, UK) at 37°C. Samples of the digested and undigested PCR product were separated electrophoretically in a 3% agarose gel and the bands visualized using ethium bromide. The carrying the factor V Leiden mutation were APC resistant.
The frequency of the factor V Leiden allele was 3.3% Acquired APC resistance: a versus c: P ϭ 0.02; b versus c: P ϭ 0.04. allele frequency was similar, 3.9% (16/414; 14 heteroIn a previous much smaller study, in which APC resistance was assessed among women with recurrent miscarriage but no zygotes and one homozygote), among the 207 women with a differentiation was made between congenital and acquired late miscarriage. There was no significant difference in the causes, it was reported that the frequency of APC resistance frequency of the factor V Leiden allele between women with was similar among women with early miscarriage compared recurrent miscarriage-early or late-and the parous control with controls (Rai et al., 1996a) . This is also the case in the population (12 heterozygotes and no homozygotes; allele present study, which emphasizes the importance of discriminatfrequency ϭ 4.0%).
ing between congenital and acquired causes of APC resistance Women with acquired APC resistance were significantly (Table II) . (P Ͻ 0.01) less likely to have had a previous live birth Previous studies reporting an increased frequency of the compared to those with a normal APC ratio (Table III) . There factor V Leiden allele among women with recurrent miscarriage was no association between APC resistance, congenital or have been based on small numbers of women, and may have acquired, and aPL positivity (Table III) . been prone to acquisition bias. For example, the study reporting the highest frequency of the factor V Leiden allele among Discussion women with recurrent miscarriage (15%) is based on those The haemostatic system plays an important role in three crucial referred for investigation to a specialist haemostasis unit stages of pregnancy-ovulation, implantation and placentation. (Brenner et al., 1997) . Similarly, prevalence studies of acquired Attention has recently focused on the potential role that APC resistance among women with recurrent miscarriage have thrombophilic defects, which predispose to the development also been based on small numbers of patients and may also of thrombosis, may play in the aetiology not only of recurrent have been prone to acquisition bias (Balasch et al., 1997; miscarriage but also of later pregnancy complications (Preston Brenner et al., 1997; Tal et al., 1999 Tal et al., ). et al., 1996 Rai et al., 1996b; Younis et al., 1997; Brenner Although both factor V Cambridge (Williamson et al., 1998 (Williamson et al., ) et al., 1999 Kupferminc et al., 1999) . This large study reports and the HR2 haplotype (Bernardi et al., 1997) have been that the frequency of acquired APC resistance is significantly reported to be associated with APC resistance, these are both higher among women with either recurrent early miscarriage rare and no common genetic cause for APC resistance apart or a previous late miscarriage compared to parous controls. In from the factor V Leiden mutation has been reported. contrast, the frequency of congenital APC resistance, due to
In contrast, high concentrations of coagulation factor VIII the factor V Leiden allele, among women with miscarriage is (Laffan and Manning, 1996) , antiphospholipid antibodies similar to that of appropriately matched controls. The factor (Aznar et al., 1997 ), pregnancy (Cumming et al., 1995 and V Leiden allele frequency in the control group is in agreement the combined oral contraceptive pill (Olivieri et al., 1995) are with that previously reported in two studies among 381 associated with acquired APC resistance. In this study, no asymptomatic, unrelated Caucasians (Beauchamp et al., 1994;  woman was taking the contraceptive pill and all were tested at least 12 weeks after their last pregnancy. No association Rees, 1996) .
